These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 37144994)

  • 1. A novel circadian cycle-related gene signature for prognosis prediction of patients with breast cancer.
    Hu Y; Fan S; Zhu Y; Xie X
    Medicine (Baltimore); 2023 May; 102(18):e33718. PubMed ID: 37144994
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Construction of a novel mRNA-signature prediction model for prognosis of bladder cancer based on a statistical analysis.
    Li J; Cao J; Li P; Yao Z; Deng R; Ying L; Tian J
    BMC Cancer; 2021 Jul; 21(1):858. PubMed ID: 34315402
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A nomogram model based on the number of examined lymph nodes-related signature to predict prognosis and guide clinical therapy in gastric cancer.
    Li H; Lin D; Yu Z; Li H; Zhao S; Hainisayimu T; Liu L; Wang K
    Front Immunol; 2022; 13():947802. PubMed ID: 36405735
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A 7-gene signature predicts the prognosis of patients with bladder cancer.
    Tang F; Li Z; Lai Y; Lu Z; Lei H; He C; He Z
    BMC Urol; 2022 Jan; 22(1):8. PubMed ID: 35090432
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Establishment and validation of an aging-related risk signature associated with prognosis and tumor immune microenvironment in breast cancer.
    Wang Z; Liu H; Gong Y; Cheng Y
    Eur J Med Res; 2022 Dec; 27(1):317. PubMed ID: 36581948
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Integrative transcriptional characterization of cell cycle checkpoint genes promotes clinical management and precision medicine in bladder carcinoma.
    Shi WW; Guan JZ; Long YP; Song Q; Xiong Q; Qin BY; Ma ZQ; Hu Y; Yang B
    Front Oncol; 2022; 12():915662. PubMed ID: 36033441
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comprehensive
    Xu T; Xu W; Zheng Y; Li X; Cai H; Xu Z; Zou Q; Yu B
    Front Immunol; 2022; 13():931906. PubMed ID: 35958598
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development of a novel five-lncRNA prognostic signature for predicting overall survival in elderly patients with breast cancer.
    Luo Y; Zhang Y; Wu YX; Li HB; Shen D; Che YQ
    J Clin Lab Anal; 2022 Jan; 36(1):e24172. PubMed ID: 34894405
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification and development of an independent immune-related genes prognostic model for breast cancer.
    Chen L; Dong Y; Pan Y; Zhang Y; Liu P; Wang J; Chen C; Lu J; Yu Y; Deng R
    BMC Cancer; 2021 Mar; 21(1):329. PubMed ID: 33785008
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of cuproptosis-related subtypes, construction of a prognosis model, and tumor microenvironment landscape in gastric cancer.
    Wang J; Qin D; Tao Z; Wang B; Xie Y; Wang Y; Li B; Cao J; Qiao X; Zhong S; Hu X
    Front Immunol; 2022; 13():1056932. PubMed ID: 36479114
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic Signature for Lung Adenocarcinoma Patients Based on Cell-Cycle-Related Genes.
    Jiang W; Xu J; Liao Z; Li G; Zhang C; Feng Y
    Front Cell Dev Biol; 2021; 9():655950. PubMed ID: 33869220
    [TBL] [Abstract][Full Text] [Related]  

  • 12. PANoptosis-related molecular clustering and prognostic signature associated with the immune landscape and therapy response in breast cancer.
    Cao Y; Guan L; Yang L; Wei C
    Medicine (Baltimore); 2024 Sep; 103(37):e39511. PubMed ID: 39287311
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Derivation and Comprehensive Analysis of Aging Patterns in Patients with Bladder Cancer.
    Wang B; Tong F; Zhai C; Wang L; Liu Y; Wang J
    Dis Markers; 2021; 2021():3385058. PubMed ID: 34721733
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CD4+ conventional T cells-related genes signature is a prognostic indicator for ovarian cancer.
    Hua T; Liu DX; Zhang XC; Li ST; Yan P; Zhao Q; Chen SB
    Front Immunol; 2023; 14():1151109. PubMed ID: 37063862
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of a Nuclear Mitochondrial-Related Multi-Genes Signature to Predict the Prognosis of Bladder Cancer.
    Jiang X; Xia Y; Meng H; Liu Y; Cui J; Huang H; Yin G; Shi B
    Front Oncol; 2021; 11():746029. PubMed ID: 34692528
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Construction and validation of a bladder cancer risk model based on autophagy-related genes.
    Shen C; Yan Y; Yang S; Wang Z; Wu Z; Li Z; Zhang Z; Lin Y; Li P; Hu H
    Funct Integr Genomics; 2023 Jan; 23(1):46. PubMed ID: 36689018
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development of prognostic signature and nomogram for patients with breast cancer.
    Su J; Miao LF; Ye XH; Cui MS; He XF
    Medicine (Baltimore); 2019 Mar; 98(11):e14617. PubMed ID: 30882627
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of a Four Cancer Stem Cell-Related Gene Signature and Establishment of a Prognostic Nomogram Predicting Overall Survival of Pancreatic Adenocarcinoma.
    Li S; Chen R; Luo W; Lin J; Chen Y; Wang Z; Lin W; Li B; Wang J; Yang J
    Comb Chem High Throughput Screen; 2022; 25(12):2070-2081. PubMed ID: 35048799
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A Novel Aging-Related Prognostic lncRNA Signature Correlated with Immune Cell Infiltration and Response to Immunotherapy in Breast Cancer.
    Liu Z; Ren C; Cai J; Yin B; Yuan J; Ding R; Ming W; Sun Y; Li Y
    Molecules; 2023 Apr; 28(8):. PubMed ID: 37110517
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A Novel YTHDF3-Based Model to Predict Prognosis and Therapeutic Response in Breast Cancer.
    Liu J; Zhu J; Wang X; Zhou Z; Liu H; Zhu D
    Front Mol Biosci; 2022; 9():874532. PubMed ID: 35755811
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.